Genome & Company (KOSDAQ:A314130) agreed to acquire a 60% stake in List Biological Laboratories, Inc. from Karen Crawford, Linda J. Eaton Trust, Johannes Bigalke and others for KRW 30 billion on September 8, 2021. The consideration will be paid with 2 business days when all prerequisites are satisfied before the transaction is closed. For the year 2020, List Biological Laboratories reported total assets of KRW 18224 million, total debt of KRW 4314 million, total equity of KRW 13910 million, sales of KRW 9091 million and net loss of KRW 455 million. As per update on September 9, 2021, completion is expected on December 8, 2021.